LA
Standard BioTools Inc.
LAB · NASDAQ
$0.77 +4.75% (+$0.03)
1M +18.43%
Market Cap $301.3M
P/E Ratio -
Div. Yield -
ROE 18.16%
Piotroski F-Score Weak
3/9Valuation
75 /100
Cheap P/B 0.56x
P/S 3.56x
PEG N/A
Growth
0 /100
Declining Rev. growth 4.49%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 97.62%
Op. margin 94.80%
Gross margin 49.14%
Quality
2 /100
Poor Asset turnover 0.13x
ROA 13.93%
ROIC 8.25%
Debt
69 /100
Low Current ratio 9.10x
Int. coverage -6,591.47x
Debt/Equity 0.05x
Stability
42 /100
Moderate Profitable years 0
EPS volatility 9.67%
Beta 1.37x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na LAB
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Michael Egholm
Employees
387
Headquarters
Boston
Nadcházející události
03 LIS
Earnings
Upcoming earnings report